REQUEST A DEMO
Total
USD $0.00
Search more companies

Doropharm Health S.R.O. (Slovakia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Other Miscellaneous Store Retailers
Full name: Doropharm Health S.R.O. Profile Updated: July 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Doropharm Health S.R.O. is an enterprise based in Slovakia. Its main office is in Bratislava. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on June 08, 2023. The total number of employees is currently 20 - 24 (2025). There was a net sales revenue increase of 1620.07% reported in Doropharm Health S.R.O.’s latest financial highlights for 2024. During that time, Doropharm Health S.R.O.’s total assets grew by 10.24%.

Headquarters
Stara Vajnorska, 21
Bratislava; Bratislavsky; Postal Code: 83104

Contact Details: Purchase the Doropharm Health S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Doropharm Health S.R.O. report to view the information.
Registered Capital:
Purchase the Doropharm Health S.R.O. report to view the information.
Financial Auditors:
Purchase the Doropharm Health S.R.O. report to view the information.
Incorporation Date:
June 08, 2023
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Doropharm Health S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
1620.07%
Total operating revenue
1615.12%
Operating profit (EBIT)
N/A
EBITDA
2486.8%
Net Profit (Loss) for the Period
N/A
Total assets
10.24%
Total equity
11.3%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-49.01%
Quick Ratio
-0.31%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?